← Eichor
Study identifier: NCT06090994 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Condition: Colorectal Cancer  ·  Sponsor: Fudan University

PhasePhase 4
Planned participants756
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, multicenter, randomized, parallel controlled study to evaluate the effectiveness of Huaier Granule in preventing recurrence and metastasis after radical resection of colorectal cancer

This description comes directly from the study's public registry record.

Talk to the study team

Sanjun Cai, PhD  ·  +8618121299134

Fangqi Liu, PhD  ·  +8613917902221

Always discuss trial participation with your own doctor first.

Locations (9)

Harbin Medical University Cancer HospitalHarbin, Heilongjiang, ChinaNot Yet Recruiting
The First People's Hospital of ChangzhouChangzhou, Jiangsu, ChinaNot Yet Recruiting
Jiangsu People's HospitalNanjing, Jiangsu, ChinaRecruiting
Northern Jiangsu People's HospitalYangzhou, Jiangsu, ChinaRecruiting
Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, ChinaRecruiting
Sanjun CaiShanghai, Shanghai Municipality, ChinaRecruiting
Renji Hospital,Shanghai Jiao Tong University School of MedicineShanghai, Shanghai Municipality, ChinaNot Yet Recruiting
Zhejiang Cancer HospitaHangzhou, Zhejiang, ChinaNot Yet Recruiting
Ningbo Medical Center Lihuili HospitalNingbo, Zhejiang, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06090994